Press "Enter" to skip to content

Neurodegenerative Disease Market Share, Size, Industry Growth Rate, Development Status and Regional Trends Forecast to 2019-2024

Neurodegenerative Disease

The “Neurodegenerative Disease Market” report 2019 delivers up-to-date information about market changes and prospective threats, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. Moreover, it focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

Get a Sample Copy of the Report At – https://www.industryresearch.co/enquiry/request-sample/14244853

Market Overview:

  • The major factors for the growth of the neurodegenerative disease market include the rising prevalence of neurological disorders, increasing public awareness, and strong product pipeline for neurodegenerative disease treatment.
  • With increasing global population and average lifespan, the prevalence of neurological disorders is on the rise, worldwide. According to a study by the Parkinson’s Disease Foundation, the number of new cases of the disease has increased over the last 30 years. Globally, over 10 million people are living with Parkinson’s disease, according to the statistics of 2016. The Alzheimer’s Association stated that around 5.4 million people in the United States were living with Alzheimer’s disease, in 2016. This disease is the sixth-leading cause of death in the United States, and is more prevalent among people above 65 years of age, as 5.2 million out of the 5.4 million patients fall in this age bracket. The increase in global average age contributes to increased prevalence of Amyotrophic Lateral Sclerosis (ALS), since the disease is most prevalent in people above 60 years of age. According to a report, approximately 4 out of 10,000 people in the United States had ALS in 2015, which is expected to increase in the coming years. At present, around 30,000 people in the United States are estimated to be suffering from Huntington’s disease. The prevalence of these diseases among all races, genders, and geographical backgrounds is increasing with the rise in the world population. The aforementioned numbers suggest that the prevalence of neurodegenerative disorders is on the rise, contributing to the growth of the market over the forecast period.

    Top Key Players of Neurodegenerative Disease Market Are:

  • AbbVie Inc.
  • Amneal Pharmaceuticals Inc.
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann
  • La Roche Ltd
  • GlaxoSmithKline PLC
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical
  • UCB SA

    Reasons to buy:

    • In-depth analysis of the market on the global and regional level.
    • Major changes in market dynamics and competitive landscape.
    • Segmentation on the basis of type, application, geography and others.
    • Historical and future market research in terms of size, share, growth, volume & sales.
    • Major changes and assessment in market dynamics & developments.
    • Industry size & share analysis with industry growth and trends.
    • Emerging key segments and regions
    • Key business strategies by major market players and their key methods.
    • The research report covers size, share, trends and growth analysis of the Neurodegenerative Disease Market on the global and regional level.

    Inquire or Share Your Questions If Any Before the Purchasing This Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/14244853

    Scope of the Report:

  • As per the scope of this report, neurodegenerative disease is a broad term used to denote a range of conditions that primarily affect the neurons in the brain. Neurodegenerative diseases are incurable, and the degradation of neurons leads to the gradual death of neurons. The market is segmented by indication type, drug type, and geography.

    Neurodegenerative Disease market covers the outlook for overall market status, size and share. The report provides complete coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Neurodegenerative Disease market report also presents the market competition landscape and a corresponding detailed analysis of the major vendor in the market. 

    Key Market Trends:

    Parkinson’s Disease Segment by Indication Type is Expected to Be the Fastest Growing Segment

    The initial symptoms of Parkinson’s disease include shaking, rigidity, uneasiness in walking, and slowness. Anxiety and depression are very common in patients suffering from Parkinson’s disease. Anti-Parkinson drugs, such as Levodopa and Carbidopa, are the most commonly administered drugs, along with dopamine agonists. Ropinirole, Pramipexole, and Rotigotine are some common dopamine agonists prescribed for the disease. Selegiline and Rasagiline are the drugs that conserve dopamine and prevent degradation. COMT inhibitors are also administered to prevent the degradation of dopamine. According to the Parkinson’s Disease Foundation, nearly 10 million people worldwide are living with Parkinson’s disease. The risk of Parkinson’s disease increases with age. The growing aging population, especially in North America and Europe, is the primary factor propelling the growth of the market. The increasing awareness and incidences of the disease are boosting the market growth. According to the Parkinson’s Disease Foundation, medication cost for a patient with the disease is on an average USD 2,500 a year, and therapeutic surgery costs nearly USD 100,000 per person. In 2017, North America accounted for the largest market, followed by Europe and Asia-Pacific.

    North America is Expected to Dominate the Market

    North America is the most significant region in Parkinson’s drugs market. As many as one million Americans live with Parkinson’s disease (PD), which is more than the combined number of people diagnosed with multiple sclerosis, muscular dystrophy, and Lou Gehrig’s disease. According to Parkinson’s news, 2018, approximately 1.2 million people in the United States are predicted to have Parkinson’s disease by 2030. It is the second-most common neurodegenerative disorder in the United States. Also, there are thousands of patients who go undetected. As the US population continues to age, the number of people living with Parkinson disease (PD) continues to grow, and it is expected to double between 2010 and 2040. Recently, the Food and Drug Administration (FDA) approved safinamide (Xadago) tablets as an add-on treatment to levodopa/carbidopa for patients with PD, who are experiencing “off” episodes. FDA approved the drug in March 2017. On the other hand, patients are adopting the generics due to the low cost, and are further expected to restrain the patented drugs. Hence, this generic competition between the new entrants is expected to show a steady growth rate, during the forecast period.

    Neurodegenerative Disease Market Report contents include:

    – Analysis of the Neurodegenerative Disease market including revenues, future growth, market outlook

    – Historical data and forecast

    – Regional analysis including growth estimates

    – Analyzes the end user markets including growth estimates.

    – Profiles on Neurodegenerative Disease including products, sales/revenues, and market position

    – Market structure, market drivers and restraints.

    Purchase this Report (Price 4250 USD for a Single-User License) – https://www.industryresearch.co/purchase/14244853

    Detailed TOC of Neurodegenerative Disease Market Report Are:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Prevalence of Neurological Disorders
    4.2.2 Increasing Public Awareness
    4.2.3 Strong Product Pipeline for Neurodegenerative Disease Treatment
    4.3 Market Restraints
    4.3.1 Patent Expiry of Neurodegenerative Disease Treatment Products
    4.3.2 Stringent Regulatory Guidelines
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Indication Type
    5.1.1 Parkinson’s Disease
    5.1.2 Amyotrophic Lateral Sclerosis
    5.1.3 Alzheimer’s Disease
    5.1.4 Huntington Disease
    5.1.5 Other Indication Types
    5.2 By Drug Type
    5.2.1 N-methyl-D-aspartate Receptor
    5.2.2 Selective Serotonin Reuptake Inhibitor
    5.2.3 Dopamine Inhibitors
    5.2.4 Other Drug Types
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 United Kingdom
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 AbbVie Inc.
    6.1.2 Amneal Pharmaceuticals Inc.
    6.1.3 Boehringer Ingelheim International GmbH
    6.1.4 F. Hoffmann-La Roche Ltd
    6.1.5 GlaxoSmithKline PLC
    6.1.6 Merck & Co. Inc.
    6.1.7 Pfizer Inc.
    6.1.8 Teva Pharmaceutical
    6.1.9 UCB SA

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Hot-melt Adhesive Market 2019 – 2025 Estimated Global Size, Structure Analysis by Rising Status of Manufacturers, CAGR, Types, Applications, and Forecast

    Diagnostic Biomarker Market Share, Size 2019 Global Industry Analysis, Future Plans, Updates, Future Growth, Business Prospects and Forthcoming Developments Forecast to 2025

    Arabinogalactan Market 2019 Global Industry Emerging Technologies, Trends, Opportunities, Key Findings, Competition Strategies, Historical Analysis Forecast to 2025

    Terrazzo Market 2019 Share Increasing Fast with Recent Trends, Development, Revenue, Demand and Forecast to 2023 | Says Industry Research